AXA Framlington American Growth Fund - Z Income
Category US Large-Cap Growth Equity
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price
719.80p
-3.40p (-0.47%)
Fund Code
FMAMI
B4152K5
GB00B4152K59
Prices updated as at 09 May 2025
|
Prices in GBX
Investment objective
The aim of this Fund is to provide long-term capital growth over a period of 5 years or more. The Fund invests principally (meaning at least 80% of its assets) in large and medium-sized companies listed in the US. The Fund invests in shares of companies which the Manager believes are attractive investment opportunities, relative to their industry peers. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Growth
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk & rating
- Management
| Fund status | Open |
| Fund type | Unit Trust |
| Fund manager | Gregg Bridger, David Shaw |
| 840.3 | |
| 636.4 | |
| Fund comparative index | S&P 500 TR GBP |
| North America | |
| - | |
| 0.81 | |
| 0.12 | |
| 0.00 | |
| US Large-Cap Growth Equity | |
| No | |
| Fund provider | AXA Investment Managers UK Ltd |
| Share class launch date | 21 Jun 2011 |
| £982.21m | |
| - | |
| 0.00 | |
| - | |
| Annually |
Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.
